Article
MNK2 deficiency potentiates β-cell regeneration via translational regulation
13 Jun 2022
Abstract excerpt
Regenerating pancreatic β-cells is a potential curative approach for diabetes. We previously identified the small molecule CID661578 as a potent inducer of β-cell regeneration, but its target and mechanism of action have remained unknown. We now screened 257 million yeast clones and determined that CID661578 targets MAP kinase-interacting serine/threonine kinase 2 (MNK2), an interaction we genetically validated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
